Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.

Abstract

The aim of the study was to confirm whether plasma levels of interleukin-10 (IL-10) correlate with the prognosis in diffuse, large B-cell lymphoma (DLBCL) patients. Plasma IL-10 levels were determined at the time of diagnosis in a group of 157 consecutively treated, DLBCL patients. Of those, 122 patients (78%) had IL-10 plasma levels below the detection… (More)

3 Figures and Tables

Topics

  • Presentations referencing similar topics